132 related articles for article (PubMed ID: 29588134)
21. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
Li XL; Guan RJ; Li JJ
J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
[TBL] [Abstract][Full Text] [Related]
22. Withania somnifera shows a protective effect in monocrotaline-induced pulmonary hypertension.
Kaur G; Singh N; Samuel SS; Bora HK; Sharma S; Pachauri SD; Dwivedi AK; Siddiqui HH; Hanif K
Pharm Biol; 2015 Jan; 53(1):147-57. PubMed ID: 25237891
[TBL] [Abstract][Full Text] [Related]
23. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
[TBL] [Abstract][Full Text] [Related]
24. Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson's disease in rats.
Hegazy MA; Maklad HM; Samy DM; Abdelmonsif DA; El Sabaa BM; Elnozahy FY
Neurochem Int; 2017 Sep; 108():361-371. PubMed ID: 28527632
[TBL] [Abstract][Full Text] [Related]
25. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
[TBL] [Abstract][Full Text] [Related]
26. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline.
Yoshihara F; Nishikimi T; Horio T; Yutani C; Takishita S; Matsuo H; Ohe T; Kangawa K
Eur J Pharmacol; 1998 Aug; 355(1):33-9. PubMed ID: 9754936
[TBL] [Abstract][Full Text] [Related]
27. Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.
Fontoura D; Oliveira-Pinto J; Tavares-Silva M; Leite S; Vasques-Nóvoa F; Mendes-Ferreira P; Lourenço AP; Leite-Moreira AF
Rev Port Cardiol; 2014 Apr; 33(4):213-22. PubMed ID: 24780128
[TBL] [Abstract][Full Text] [Related]
28. The remodeling of connexin in the hypertrophied right ventricular in pulmonary arterial hypertension and the effect of a dual ET receptor antagonist (bosentan).
Tan XY; He JG
Pathol Res Pract; 2009; 205(7):473-82. PubMed ID: 19232841
[TBL] [Abstract][Full Text] [Related]
29. Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.
Zhang WH; Liu CP; Zhang YJ; Ji YQ; Lu WX; Zeng Q
Scand Cardiovasc J; 2012 Dec; 46(6):374-80. PubMed ID: 22971207
[TBL] [Abstract][Full Text] [Related]
30. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
[TBL] [Abstract][Full Text] [Related]
31. Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension.
Mathew R; Gloster ES; Sundararajan T; Thompson CI; Zeballos GA; Gewitz MH
J Appl Physiol (1985); 1997 May; 82(5):1493-8. PubMed ID: 9134898
[TBL] [Abstract][Full Text] [Related]
32. Modafinil improves monocrotaline-induced pulmonary hypertension rat model.
Lee H; Kim KC; Cho MS; Suh SH; Hong YM
Pediatr Res; 2016 Jul; 80(1):119-27. PubMed ID: 26959484
[TBL] [Abstract][Full Text] [Related]
33. Melatonin as a preventive and curative therapy against pulmonary hypertension.
Maarman G; Blackhurst D; Thienemann F; Blauwet L; Butrous G; Davies N; Sliwa K; Lecour S
J Pineal Res; 2015 Oct; 59(3):343-53. PubMed ID: 26201290
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of γ-aminobutyric acid on right ventricular pressure and pulmonary vascular remodeling in experimental pulmonary hypertension.
Suzuki R; Maehara R; Kobuchi S; Tanaka R; Ohkita M; Matsumura Y
Life Sci; 2012 Oct; 91(13-14):693-8. PubMed ID: 22542556
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
[TBL] [Abstract][Full Text] [Related]
36. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
[TBL] [Abstract][Full Text] [Related]
37. The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats.
Bal E; Ilgin S; Atli O; Ergun B; Sirmagul B
Hum Exp Toxicol; 2013 Jul; 32(7):766-74. PubMed ID: 23821593
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats.
Yang DL; Zhang HG; Xu YL; Gao YH; Yang XJ; Hao XQ; Li XH
Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):150-5. PubMed ID: 19566840
[TBL] [Abstract][Full Text] [Related]
39. DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension.
Kang KK; Ahn GJ; Sohn YS; Ahn BO; Kim WB
J Int Med Res; 2003; 31(6):517-28. PubMed ID: 14708417
[TBL] [Abstract][Full Text] [Related]
40. Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension.
Steven S; Oelze M; Brandt M; Ullmann E; Kröller-Schön S; Heeren T; Tran LP; Daub S; Dib M; Stalleicken D; Wenzel P; Münzel T; Daiber A
Oxid Med Cell Longev; 2017; 2017():4353462. PubMed ID: 28337251
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]